Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

Trial conducted to evaluate newer methods of pain relief for limb injuries

Jul 9, 2014AaronNews

SINGAPORE: A year-long trial is being conducted on two medications to ensure patients get a faster and more effective delivery of pain relief.

The Singapore General Hospital (SGH) and Singapore Civil Defence Force (SCDF) will study the suitability of Penthrox and Tramadol for early pain relief.

Penthrox is delivered through an inhaler while Tramadol is injection-based.

The trial, which started in February, involves 400 patients who sustained limb injuries over a one-year period.

The efficacy of the medications will be evaluated based on how patients rated their own pain on a scale of 1 to 10 at 5, 10, 15 and 20 minutes after the medicine is administered.

At the end of the trial, recommendations will be made to roll out the most effective form of medication to ambulances.

Doctors say these medications are more portable compared to what paramedics carry at present.

Associate Professor Marcus Ong, senior consultant at Department of Emergency Medicine at SGH, said: “Currently, our SCDF ambulances use a gas called Entonox, or in layperson’s term, laughing gas, for relief of pain. The problem with Entonox is it is cylinder-based. So it is a tank that weighs at least 5kg and it is not easy to bring to, for example, to a car crash victim and deliver it to the place they are found.”

As published on TradeNewswire.net – Tuesday 8 July 2014

http://www.tradenewswire.net/trial-conducted-to-evaluate-newer-methods-of-pain-relief-for-limb-injuries/#more-28212

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter